Eli Lilly has a supercharged form of the weight-loss drug Ozempic that will likely be prescribed to every diabetes patient who can afford it (unlimited price gouging applies). It’s expected to be the industry’s first drug with $100+ Billion per year in revenues.
With a bought & paid for Congress, I believe Lilly’s pricing power remains secure.
intercst